Vivanza Biosciences Closes Trading Window for Q1 FY27 Results

Vivanza Biosciences Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is effective from July 1st, 2026, and will remain in effect until 48 hours after the declaration of its standalone and consolidated financial results for the quarter ended June 30th, 2026. The measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and applies to promoters, directors, KMPs, designated persons, connected persons, and their immediate relatives. The company will announce the board meeting date for financial results in due course.